Neoadjuvant chemotherapy should only be considered in patients with cT3-T4a muscle-invasive bladder cancer | van Beek | Uro-Technology Journal

Neoadjuvant chemotherapy should only be considered in patients with cT3-T4a muscle-invasive bladder cancer

Sytse C. van Beek, Noor van Ginkel, Joost L. Boormans, André N. Vis, Dutch Cystectomy Snapshot Research Group

Abstract

Not available

FRIENDLINKS

THE ANT JOURNALS

Subscribe to receive issue release notifications
and newsletters from journals